We did not observe that ABCB10 loss worsened liver neutrophil inflammation or metabolism in ASH, as no upregulation in liver MPO content, no decreases in mitochondrial fat oxidation capacity and no exacerbation of hepatic steatosis were observed in ABCB10 L-KO mice under the NIAAA model. This evidence concerns the gene ABCB10 and fatty liver disease.